Insider Trades - GRANADILLO PEDRO P

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

GRANADILLO PEDRO P: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
Dendreon Corporation Director NasdaqGS:DNDN (historical quotes, profile, SEC, other insiders)	3-Jan-13	62,251	Direct
Haemonetics Corporation Common Director NYSE:HAE (historical quotes, profile, SEC, other insiders)	12-Nov-12	6,626	Direct
NPS Pharmaceuticals, Inc. Director NasdaqGM:NPSP (historical quotes, profile, SEC, other insiders)	7-Feb-13	15,225	Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
7-Feb-13 15,225 NPSP Acquisition (Non Open Market)
3-Jan-13 25,000 DNDN Acquisition (Non Open Market) at $0 per share.
12-Nov-12 16,000 HAE Option Exercise at $29.90 - $52.76 per share.
12-Nov-12 16,000 HAE Sale at $80.40 per share.
(Proceeds of $1,286,400)
13-Aug-12 6,000 HAE Option Exercise at $44.74 per share.
(Cost of $268,440)
13-Aug-12 6,000 HAE Sale at $70.05 per share.
(Proceeds of $420,300)
27-Jul-12 1,031 HAE Acquisition (Non Open Market) at $0.01 per share.
(Value of $10)
7-Feb-12 15,225 NPSP Acquisition (Non Open Market) at $0 per share.
3-Jan-12 25,000 DNDN Acquisition (Non Open Market) at $0 per share.
15-Aug-11 850 HAE Sale at $59.74 per share.
(Proceeds of $50,779)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
7-Feb-13	15,225	NPSP	Acquisition (Non Open Market)
3-Jan-13	25,000	DNDN	Acquisition (Non Open Market) at $0 per share.
12-Nov-12	16,000	HAE	Option Exercise at $29.90 - $52.76 per share.
12-Nov-12	16,000	HAE	Sale at $80.40 per share. (Proceeds of $1,286,400)
13-Aug-12	6,000	HAE	Option Exercise at $44.74 per share. (Cost of $268,440)
13-Aug-12	6,000	HAE	Sale at $70.05 per share. (Proceeds of $420,300)
27-Jul-12	1,031	HAE	Acquisition (Non Open Market) at $0.01 per share. (Value of $10)
7-Feb-12	15,225	NPSP	Acquisition (Non Open Market) at $0 per share.
3-Jan-12	25,000	DNDN	Acquisition (Non Open Market) at $0 per share.
15-Aug-11	850	HAE	Sale at $59.74 per share. (Proceeds of $50,779)